In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Vertex Pharmaceuticals Inc. gained US approval for the first new type of painkiller in more than two decades, paving the way for a safer alternative to addictive opioids that have been linked to ...
Eagan-based Prime Therapeutics has been ordered to pay $10 million in damages after federal arbitration found it engaged in ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
During the year ending last August, according to preliminary estimates from the Centers for Disease Control and Prevention ...